鉴定杆细胞特异性受体对于伪过敏药物反应至关重要
Benjamin D McNeil1, Priyanka Pundir2, Sonya Meeker3
1The Solomon H. Snyder Department of Neuroscience, Department of Neurosurgery, Center for Sensory Biology, Johns Hopkins University, School of Medicine, Baltimore, Maryland 21205, USA.
Nature
|December 18, 2014
概括
研究人员确定Mrgprb2是乳腺细胞激活中基本分泌剂的关键受体. 这一发现为伪过敏药物反应提供了一个新的小鼠模型和潜在的治疗点.
科学领域:
- 免疫学和药理学
- 细胞生物学 细胞生物学
- 药物发现 药物发现 药物发现
背景情况:
- 乳腺细胞在过敏反应中至关重要,释放诸如组胺等介质.
- 它们不仅对IgE做出反应,还对包括药物在内的基本分泌剂做出反应.
- 这些秘密的受体一直是一个长期以来的研究问题.
研究的目的:
- 为了确定负责基本分泌剂诱导的巨细胞激活的受体.
- 研究这种受体在药物诱导的伪过敏反应中的作用.
- 探索潜在的治疗目标,以减轻药物的不良影响.
主要方法:
- 利用Mrgprb2-null突变小鼠来评估瘤细胞的反应.
- 研究了各种分泌剂和FDA批准的药物激活小鼠 (Mrgprb2) 和人类 (MRGPRX2) 受体的活性.
- 在野生型和突变小鼠中分析了组胺释放,炎症,呼吸道收缩和过敏反应.
主要成果:
- 确定了Mrgprb2作为单一的受体,它调解了小鼠巨细胞的基本分泌剂激活.
- 已经证明,Mrgprb2及其人类正经体MRGPRX2被许多类药物激活,导致注射部位和伪过敏反应.
- 证明Mrgprb2缺乏消除了分泌物诱导反应,并显著减少了药物诱导的过敏性症状.
结论:
- Mrgprb2是基本分泌物的主要受体,为研究这些反应提供了一个新的小鼠模型.
- MRGPRX2是对许多常见药物的伪过敏反应的关键调解者.
- MRGPRX2代表了一个潜在的治疗目标,用于减少特定药物诱导的不良影响.
相关概念视频
01:27Allergic Drug Reactions
1.6K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.6K
01:30Drug Toxicity: Allergic Reactions
182
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
182
01:30Allergic Reactions: Anaphylaxis
238
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
238
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.5K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.5K
02:06Allergic Reactions
34.4K
Overview
34.4K
00:42Cross-reactivity
34.1K
Overview
34.1K